Cargando…
Mucosal delivery of RNA vaccines by Newcastle disease virus vectors
The rapid evolution of SARS-CoV-2 since its pandemic outbreak has underscored the need for improved SARS-CoV-2 vaccines that efficiently reduce not only hospitalizations and deaths, but also infections and transmission. This might be achieved by a new generation of intranasally administered SARS-CoV...
Autor principal: | García-Sastre, Adolfo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9552541/ https://www.ncbi.nlm.nih.gov/pubmed/36245642 http://dx.doi.org/10.1016/j.crimmu.2022.10.001 |
Ejemplares similares
-
From Alpha to omicron: The response of T cells
por: Grifoni, Alba, et al.
Publicado: (2022) -
Alicante-Winter Immunology Symposium in Health (A-Wish) and the Boulle-SEI awards: A collaboration between the Spanish Society for immunology, the University of Alicante and the Jean Boulle Group to honor the Balmis Expedition
por: Ochando, Jordi, et al.
Publicado: (2022) -
T cell immunity is key to the pandemic endgame: How to measure and monitor it
por: Schwarz, Megan, et al.
Publicado: (2022) -
Nature of viruses and pandemics: Coronaviruses
por: Enjuanes, Luis, et al.
Publicado: (2022) -
Recombinant Newcastle Disease Virus as a Vaccine Vector for Cancer Therapy
por: Vigil, Adam, et al.
Publicado: (2008)